A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
Public ClinicalTrials.gov record NCT04030143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-label, Multiple-dose, Randomized, Parallel-arm, Safety, Tolerability, and Pharmacokinetic Trial of Aripiprazole Intramuscular Depot Administered in the Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to determine the safety and tolerability of multiple-dose administrations of aripiprazole, to establish the similarity of aripiprazole concentrations on the last day of the dosing interval following the final administration of aripiprazole into the gluteal muscle site, and to establish the similarity of aripiprazole exposure over the dosing interval following the administration of aripiprazole into the gluteal muscle site in adult participants with schizophrenia or bipolar I disorder.
Study identification
- NCT ID
- NCT04030143
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 266 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2019
- Primary completion
- Jul 7, 2020
- Completion
- Jul 7, 2020
- Last update posted
- Nov 17, 2023
2019 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Woodland International Research Group | Rogers | Arkansas | 72758 | — |
| CITrials - Bellflower | Bellflower | California | 90706 | — |
| Collaborative Neuroscience Network | Garden Grove | California | 92845 | — |
| California Clinical Trials Medical Group | Glendale | California | 91206 | — |
| Synergy Research Centers | Lemon Grove | California | 91945 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| California Neuropsychopharmacology Clinical Research Institute San Diego | San Diego | California | 92102 | — |
| Collaborative Neuroscience Network - South Bay | Torrance | California | 90502 | — |
| Research Centers of America | Hollywood | Florida | 33024 | — |
| Segal Institute For Clinical Research - West Broward Outpatient Clinic | Miami Lakes | Florida | 33016 | — |
| Atlanta Center for Medical Research - Atlanta | Atlanta | Georgia | 30331 | — |
| CBH Health | Gaithersburg | Maryland | 20877 | — |
| St. Louis Clinical Trials | St Louis | Missouri | 63141 | — |
| Altea Research Institute - Las Vegas | Las Vegas | Nevada | 89102 | — |
| Hassman Research Institute | Marlton | New Jersey | 08009 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| Carolina Clinical Trials | Charleston | South Carolina | 29407 | — |
| Community Clinical Research | Austin | Texas | 78754 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04030143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2023 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04030143 live on ClinicalTrials.gov.